Dr. Katherine Van Loon on Monitoring Recurrences in Gastrointestinal Cancers
Katherine Van Loon, MD, discusses identifying recurrences in gastrointestinal cancers at a point where patients can receive further therapy.
Katherine Van Loon, MD, gastrointestinal cancer specialist, University of California, San Francisco, discusses identifying recurrences in gastrointestinal cancers at a point where patients can receive further therapy.
Van Loon says that oncologists need further research into how often and for how long patients with gastrointestinal cancers should be monitored. She adds that current guidelines state that patients should be followed up on for approximately five years, though recurrences have happened as far out as 10 years.
FDA Grants RMAT Designation to Nogapendekin Alfa in Pancreatic Cancer
February 28th 2025The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with promising survival data in metastatic pancreatic cancer and non–small cell lung cancer.
Read More
